Skip to main navigation Skip to search Skip to main content

Differentiation of acute promyelocytic leukemia cell induced by 1,25- dihydroxyvitamin D3 and pentoxifylline (Trental®)

  • Women and Children's Hospital of Buffalo

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Human promyelocytic leukemia cell line HL-60 in tissue culture was treated with various concentrations of 1,25-dihydroxyvitamin D3, (D3) pentoxifylline (Px) or in combinations. Differentiation to normal granulocytes or monocytes was evaluated by nitroblue tetrazolium (NBT) reducing capacity and morphologic criteria. (D3) produced monocytic differentiation, but sub- differentiation inducing doses of (Px) had no effect. In previous studies we found higher doses of (Px) to produce granulocytic differentiation in vitro and in vivo.

Original languageEnglish
Pages (from-to)385-388
Number of pages4
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume79
Issue number3
StatePublished - 1993

Fingerprint

Dive into the research topics of 'Differentiation of acute promyelocytic leukemia cell induced by 1,25- dihydroxyvitamin D3 and pentoxifylline (Trental®)'. Together they form a unique fingerprint.

Cite this